Foresite Capital Management IV, LLC / ACRS
Foresite Capital Management IV, LLC’s Aclaris Therapeutics Inc Position
Does Foresite Capital Management IV, LLC own Aclaris Therapeutics Inc (ACRS)? Not currently — the last reported position was 2.81M shares worth $19M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$19M
Q3 2023
Shares
2.81M
% of Portfolio
+10.68%
Quarters Held
13
position exited
Position History ACRS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 2.81M | $19M | +10.68% |
| Q2 2023 | 2.81M | $29M | +14.32% |
| Q1 2023 | 2.81M | $23M | +11.79% |
| Q4 2022 | 2.81M | $44M | +18.89% |
| Q3 2022 | 2.81M | $44M | +14.21% |
| Q2 2022 | 2.81M | $39M | +10.56% |
| Q1 2022 | 2.90M | $50M | +13.98% |
| Q4 2021 | 3.40M | $49M | +10.17% |
| Q3 2021 | 3.40M | $61M | +9.01% |
| Q2 2021 | 3.40M | $60M | +8.07% |
| Q1 2021 | 3.40M | $86M | +10.26% |
| Q4 2020 | 951.4K | $6M | +0.67% |
| Q3 2020 | 144.9K | $372,000 | +0.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of ACRS.